Guide use of BP meds during pregnancy

As a cardiovascular pharmacist, more questions arise about managing chronic hypertension in pregnancy due to increasing maternal age, obesity, etc. We know to treat all pregnant patients with severe hypertension 160/110 mm Hg or above. But treatment of nonsevere chronic hypertension, such as 140/90 or more, hasn’t been clear-cut, due to limited evidence.

Now data suggest that aiming for a BP under 140/90 for nonsevere chronic hypertension in pregnancy improves outcomes (preeclampsia, etc) without increasing risk of low-birth-weight babies. That’s why recent guidance recommends 140/90 as the threshold for adding or stepping up treatment of chronic hypertension in pregnancy, which may lead to BP meds being used more often. Guide use of BP meds if patients are, or may become, pregnant...

  • Advise using nifedipine ER or labetalol first. These meds aren’t linked to significant fetal adverse outcomes.
  • Don’t jump to other CCBs, they don’t have as much safety data.
  • Avoid atenolol and caution about using beta-blockers other than labetalol, because they may impair fetal growth.
  • Methyldopa is often thought of if other first-line meds aren’t enough, based on its long history of safety in pregnancy. But point out that it’s been discontinued with no estimated return date.
  • Generally save thiazides as a second-line option due to possible hypovolemia, especially in the first couple weeks of therapy.

REFERENCES

Post a Comment

Previous Post Next Post